BlackRock Capital Allocation Term Trust (NYSE:BCAT) Hits New 12-Month Low - Should You Sell?

Key Points

• BCAT shares hit a new 52-week low, falling to $13.43 during Wednesday trading and remaining below both its 50-day and 200-day moving averages.
• The fund announced a monthly dividend of $0.2501 per share, equivalent to $3.00 annually and a reported 22.0% dividend yield.
• Institutional investors own 36.12% of BCAT, with several firms increasing their positions during the second quarter.

BlackRock Capital Allocation Term Trust (NYSE:BCAT - Get Free Report) shares reached a new 52-week low during trading on Wednesday. The company traded as low as $13.43 and last traded at $13.6540, with a volume of 1172905 shares trading hands. The stock had previously closed at $13.56.

BlackRock Capital Allocation Term Trust Stock Performance

The company has a 50 day simple moving average of $15.40 and a 200-day simple moving average of $15.32.

BlackRock Capital Allocation Term Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, December 22nd. Investors of record on Friday, December 11th will be issued a dividend of $0.2501 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 22.0%. The ex-dividend date of this dividend is Friday, December 11th.

Institutional Trading of BlackRock Capital Allocation Term Trust

Several hedge funds and other institutional investors have recently bought and sold shares of BCAT. NewEdge Advisors LLC boosted its stake in shares of BlackRock Capital Allocation Term Trust by 12.4% in the 2nd quarter. NewEdge Advisors LLC now owns 19,830 shares of the company's stock valued at $316,000 after purchasing an additional 2,192 shares in the last quarter. Baird Financial Group Inc. lifted its stake in BlackRock Capital Allocation Term Trust by 2.0% in the second quarter. Baird Financial Group Inc. now owns 90,490 shares of the company's stock worth $1,442,000 after purchasing an additional 1,815 shares during the last quarter. Corient Private Wealth LP boosted its position in BlackRock Capital Allocation Term Trust by 23.5% during the second quarter. Corient Private Wealth LP now owns 34,651 shares of the company's stock valued at $552,000 after buying an additional 6,592 shares during the period. HighTower Advisors LLC grew its stake in shares of BlackRock Capital Allocation Term Trust by 72.7% during the second quarter. HighTower Advisors LLC now owns 29,218 shares of the company's stock valued at $465,000 after buying an additional 12,299 shares during the last quarter. Finally, Advisory Solutions Group LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust in the second quarter worth about $213,000. Hedge funds and other institutional investors own 36.12% of the company's stock.

About BlackRock Capital Allocation Term Trust

BlackRock Capital Allocation Term Trust NYSE: BCAT is a diversified, closed-end management investment company advised by BlackRock Advisors, LLC. The fund seeks to provide total return through a combination of current income and capital appreciation.

BCAT invests across both equity and debt markets. Its portfolio may include common stocks, preferred securities, convertible securities, investment-grade and below-investment-grade corporate bonds, loans, and other fixed-income instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.